Human Genome Epidemiology Literature Finder
|
Records 1 - 2 (of 2 Records) |
| Query Trace: Disease and SUCLG2[original query] |
|---|
| SUCLG2 identified as both a determinator of CSF Aß1-42 levels and an attenuator of cognitive decline in Alzheimer's disease.
Human molecular genetics 2014 Dec 23 (24): 6644-58. Ramirez Alfredo, van der Flier Wiesje M, Herold Christine, Ramonet David, Heilmann Stefanie, Lewczuk Piotr, Popp Julius, Lacour André, Drichel Dmitriy, Louwersheimer Eva, Kummer Markus P, Cruchaga Carlos, Hoffmann Per, Teunissen Charlotte, Holstege Henne, Kornhuber Johannes, Peters Oliver, Naj Adam C, Chouraki Vincent, Bellenguez Céline, Gerrish Amy, , , Heun Reiner, Frölich Lutz, Hüll Michael, Buscemi Lara, Herms Stefan, Kölsch Heike, Scheltens Philip, Breteler Monique M, Rüther Eckart, Wiltfang Jens, Goate Alison, Jessen Frank, Maier Wolfgang, Heneka Michael T, Becker Tim, Nöthen Markus |
| Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. Journal of neurology 2021 1 268 (6): 2192-2207. Chakrabarty Sanjiban, Govindaraj Periyasamy, Sankaran Bindu Parayil, Nagappa Madhu, Kabekkodu Shama Prasada, Jayaram Pradyumna, Mallya Sandeep, Deepha Sekar, Ponmalar J N Jessiena, Arivinda Hanumanthapura R, Meena Angamuthu Kanikannan, Jha Rajan Kumar, Sinha Sanjib, Gayathri Narayanappa, Taly Arun B, Thangaraj Kumarasamy, Satyamoorthy Kapaet |
- Page last reviewed:Feb 1, 2024
- Content source:

